↓ Skip to main content

The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics

Overview of attention for article published in European Journal of Heart Failure, July 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
2 news outlets
policy
2 policy sources
twitter
83 X users
patent
3 patents

Citations

dimensions_citation
169 Dimensions

Readers on

mendeley
264 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics
Published in
European Journal of Heart Failure, July 2019
DOI 10.1002/ejhf.1548
Pubmed ID
Authors

John J.V. McMurray, David L. DeMets, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod, Anna Maria Langkilde, Felipe A. Martinez, Olof Bengtsson, Piotr Ponikowski, Marc S. Sabatine, Mikaela Sjöstrand, Scott D. Solomon, on behalf of the DAPA‐HF Committees and Investigators

X Demographics

X Demographics

The data shown below were collected from the profiles of 83 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 264 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 264 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 29 11%
Researcher 27 10%
Student > Master 20 8%
Student > Ph. D. Student 18 7%
Other 17 6%
Other 48 18%
Unknown 105 40%
Readers by discipline Count As %
Medicine and Dentistry 94 36%
Pharmacology, Toxicology and Pharmaceutical Science 13 5%
Biochemistry, Genetics and Molecular Biology 9 3%
Nursing and Health Professions 9 3%
Agricultural and Biological Sciences 5 2%
Other 26 10%
Unknown 108 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 73. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2024.
All research outputs
#593,856
of 25,539,438 outputs
Outputs from European Journal of Heart Failure
#133
of 2,536 outputs
Outputs of similar age
#12,493
of 360,185 outputs
Outputs of similar age from European Journal of Heart Failure
#9
of 42 outputs
Altmetric has tracked 25,539,438 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,536 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,185 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.